Statistics from the Nigeria Centre for Disease Control and Prevention reveal a concerning trend: Mpox cases are on the rise, especially among males. Since January 2024, 67% of Mpox cases in Nigeria have been in males, with men accounting for about 70% of the 6,001 suspected and confirmed cases since September 2017.
Children under five are the most affected, followed by the 26-30 and 46-50 age groups. Despite the high number of cases, there have been no fatalities in 2024, a positive development compared to previous years.
Mpox, caused by the monkeypox virus, can cause a painful rash, swollen lymph nodes, and fever, with potential serious complications. The World Health Organization has declared Mpox a global public health emergency, emphasizing the need for containment efforts.
To combat the spread, the WHO recently approved the MVA-BN vaccine for Mpox, which was donated to Nigeria by the United States government. This vaccine marks a crucial step in controlling the outbreak and protecting the population from this infectious disease.
[ad_2]
Source link